Physician profile
Kyle David Toti
NPI 1669735791
$1,461.11
in general payments reported to CMS, 2019-2025
15 companies · $498 in 2025
The $498 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.55 · 2021: $12.72 · 2022: $176 · 2023: $401 · 2024: $362 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,259.86 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,063.71 | 2021-2025 | Vraylar, Ubrelvy |
| Pfizer INC. | $66.82 | 2023-2025 | |
| Abbott Laboratories | $51.01 | 2022-2025 | Freestyle Libre 3 |
| Axsome Therapeutics, INC. | $46.01 | 2023-2024 | Auvelity |
| Astrazeneca Pharmaceuticals LP | $36.15 | 2023-2024 | Airsupra, Farxiga |
| Novo Nordisk INC | $30.43 | 2020-2025 | Wegovy |
| Viatris Specialty LLC | $21.88 | 2025 | Yupelri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.80 | 2022 | |
| Sumitomo Pharma America, INC. | $20.57 | 2023-2025 | Gemtesa |
| Biohaven Pharmaceutical Holding Company LTD. | $19.75 | 2022 | |
| Exact Sciences Corporation | $19.04 | 2025 | The Cologuard Plus Collection Kit |
| Neurocrine Biosciences, INC. | $17.91 | 2024 | Ingrezza |
| Janssen Pharmaceuticals, INC | $17.37 | 2024 | Spravato |
| Dexcom, INC. | $15.07 | 2024 | Dexcom G6 Transmitter |
| Kowa Pharmaceuticals America, INC. | $13.59 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Toti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.